Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what steps his Department is taking to support research into antimicrobial resistance in relation to sepsis treatment.

The Department funds research through the National Institute for Health and Care Research (NIHR). Over the past five years, the NIHR has allocated over £6 million in programme funding to support research into antimicrobial resistance in relation to sepsis treatment. The funded research studies multiple aspects of sepsis treatment, including optimising treatment for sepsis and investigating the impact of antibiotics in patients with sepsis.

The Department also funds sepsis research through investment in NIHR infrastructure. For example, NIHR Biomedical Research Centres (BRCs) support translational research, to move scientific discoveries toward patient benefit. The NIHR Sheffield BRC is conducting research to better understand how different blood components contribute to the development of sepsis, to improve patient outcomes and identify potential targets for new sepsis treatments.

The NIHR welcomes funding applications for research into any aspect of human health and care, including into antimicrobial resistance in relation to sepsis treatment. These applications are subject to peer review and judged in open competition, with awards being made on the basis of the importance of the topic to patients and health and care services, value for money, and scientific quality. The NIHR supports translational and applied research, working closely with the life sciences industry, medical research charities, and UK Research and Innovation.